Skip to main content
Fig. 3 | Cancer Communications

Fig. 3

From: Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives

Fig. 3

Brief procedures for DC-based immunotherapy. For DC activation in vivo, various DC agonists were injected directly into patients. For DC vaccine construction in vitro, PBMCs were isolated from patients and polarized into DC in the presence of cytokines. After modified with antigen or DC activation factors, ex vivo-generated DCs were feedback to patients to get therapeutic effects. DC: dendritic cells; PBMC: peripheral blood mononuclear cells

Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us